Read about Ajanta Pharma Ltd company details like share price, management, news and more at IIFL Capital.

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...